Mantle Cell Lymphoma (MCL) Terminated Phase 2 Trials for Vorinostat (DB02546)

Also known as: Mantle Cell Lymphomas / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS

DBCOND0071979 (Mantle Cell Lymphoma (MCL))Terminated2 IdentifierTitlePurposeDrugs
NCT01578343Vorinostat Plus FND in Relapsed or Refractory Mantle Cell LymphomaTreatment
NCT01500538A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)Treatment